Corporate
Sep. 26, 2007
Latham Represents Seller in $310 Million Pediatric Deal
LOS ANGELES - Latham & Watkins attorneys represented San Diego-based Verus Pharmaceuticals, which focuses on children's medical needs, in the sale for $310 million of its pediatric asthma programs to pharmaceutical giant AstraZeneca.
Daily Journal Staff Writer
LOS ANGELES ? Latham & Watkins attorneys represented San Diego-based Verus Pharmaceuticals, which focuses on children?s medical needs, in the $310 million sale of its pediatric asthma programs to pharmaceutical giant AstraZeneca.
Under the terms of the deal, which was announced Monday, Verus will receive $30 million upfront, as well as developme...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In